SEC Filing Analysis: NATIONAL RESEARCH CORP (NRC)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director received a routine, non-cash grant of stock options as compensation for board service, with negligible impact on shareholder dilution.
• Market Impact: Neutral. This type of compensatory grant is standard practice and typically does not influence market sentiment or trading activity.

Company Information

Field	Value
Company	NATIONAL RESEARCH CORP
Ticker Symbol	NRC
CIK	0000070487
Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Insider Information

Field	Value
Name	Wheeler Penny Ann
CIK	0001856610
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-17
Transaction Code	A (Grant)
Security Type	Director Stock Option (Right to Buy)
Shares Involved	22,625
Price Per Share	$0.00
Total Value	$0
Shares Owned After	22,625 (Derivative securities)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted (Underlying)	22,625
% of Shares Outstanding	0.098%
Post-Transaction Ownership (Potential)	22,625 shares (0.098% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For NATIONAL RESEARCH CORP, a company with a market capitalization of approximately $280 million, this grant has no immediate monetary value and is therefore immaterial from a market cap perspective.
• Ownership Concentration: This grant establishes a new potential holding for the director, representing less than 0.1% of total shares outstanding. This does not significantly alter insider ownership concentration.
• Dilution Impact: The grant represents options to acquire 22,625 shares, which is approximately 0.098% of the 23,063,517 shares outstanding. This level of potential dilution is negligible and considered routine for incentive plans.
• Transaction Significance: The transaction's significance is low. It is a non-cash award with a value of $0 and represents a very small fraction of the company's outstanding shares. It aligns with standard corporate governance practices for director compensation.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Stock option grants to directors are a common form of compensation and are not typically interpreted by the market as a bullish or bearish signal regarding the company's future prospects. The transaction does not involve open market activity.

Volume & Sentiment

• Expected Volume Impact: None. As this is a grant and not an open-market transaction, it will not directly impact trading volume.
• Sentiment Indicator: Neutral. This filing is informational and relates to executive compensation rather than an insider's investment decision.

Investment Insights

Positive Market Indicators

• Aligning director interests with shareholders through equity-based compensation is generally seen as a positive governance practice.

Risk Factors

• No immediate risk factors are apparent from this filing. The potential shareholder dilution is minimal.

Key Takeaways

1. Routine Compensation: This is a standard grant of stock options to a director for their service on the board.
2. No Market Signal: The transaction was executed at $0 per share, indicating it is an award, not an open-market purchase reflecting insider confidence.
3. Minimal Dilution: The potential dilution from the exercise of these options is less than 0.1%, which is immaterial to existing shareholders.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote clarifies the grant was made under the '2025 Omnibus Incentive Plan' for participation in two in-person meetings during 2025. The options have an exercise price of $11.61 and a 10-year expiration date.
• Market Environment: This is a routine corporate action, independent of broader market conditions.